SpringWorks Therapeutics 8-K Report: Key Updates and Financial Insights
Based on the provided section of the financial report, here are the extracted key pieces of information:
- Entity Information:
- Company Name: SpringWorks Therapeutics, Inc.
- Incorporation State: Delaware (DE)
- CIK Number: 0001773427
- SEC File Number: 001-39044
- EIN: 83-4066827
- Headquarters Address: 100 Washington Blvd, Stamford, CT 06902
- Contact Number: 203-883-9490
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: February 11, 2025
- Stock Information:
- Common Stock Par Value: $0.0001 per share
- Stock Ticker Symbol: SWTX
- Exchange: NASDAQ
- Reporting Date Context:
- Report Date: As of February 11, 2025
- Period Start Date: February 11, 2025
- Period End Date: February 11, 2025
- Unit of Measure:
- The report uses USD (U.S. Dollars) and shares as units of measurement.
Insights:
- The report indicates that it is a current report (8-K) which typically includes important company news that shareholders need to be aware of, suggesting that it may contain material information relevant to investors.
- The company is publicly traded on NASDAQ, which allows for easier access to financial data and stock performance for investors.
- Understanding the par value of stock can provide insights into the company’s financing structure, although the very low par value indicates it is primarily for legal purposes rather than reflecting actual value.
- The specific reporting date may indicate the company is responding to an event or change that occurred on that date, warranting timely disclosure.
This information can be crucial for investors, analysts, and stakeholders in assessing the company's status and making informed decisions.